ArticleDiagnostic pathology2014

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4.

Fang-ling Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.